Latest News

  • REGULATORY

    4 Dec 2025

    HHS Shift Reshapes Momentum and Strategy Across mRNA Sector

  • INNOVATION

    3 Dec 2025

    AI Tools Edge Into mRNA Design

  • PARTNERSHIPS

    2 Dec 2025

    A New mRNA Alliance Tests What Comes After COVID

  • INVESTMENT

    1 Dec 2025

    Can A Big Bet On mRNA Reset Biotech’s Pace?

The Push to Turn mRNA Into a Cancer Weapon

Syringe drawing dose from medical vial for mRNA vaccine research

PARTNERSHIPS

25 Nov 2025

Pfizer and BioNTech deepen mRNA cancer vaccine development as competition grows and FDA signals supportive pathways

Person walking toward large federal building with strong morning shadows

REGULATORY

4 Dec 2025

HHS Shift Reshapes Momentum and Strategy Across mRNA Sector

HHS exit from key BARDA vaccine projects forces mRNA players to rethink priorities and chase new paths for growth

Robotic hand interacting with molecular structures symbolizing AI-driven mRNA design.

INNOVATION

3 Dec 2025

AI Tools Edge Into mRNA Design

Early data from platforms like GEMORNA hint at faster mRNA design as drug makers weigh emerging AI approaches

Silhouette of a hand holding a syringe in front of BioNTech and Pfizer logos on a bright display background

PARTNERSHIPS

2 Dec 2025

A New mRNA Alliance Tests What Comes After COVID

Pfizer and BioNTech launch a collaborative mRNA R&D initiative that could shape future therapeutic development

Pipette dropping blue liquid into test tubes with DNA strand in background

INVESTMENT

1 Dec 2025

Can A Big Bet On mRNA Reset Biotech’s Pace?

Strand Therapeutics' $153M raise fuels momentum in targeted mRNA therapies and hints at a fast-advancing biotech shift

Syringe drawing dose from medical vial for mRNA vaccine research

PARTNERSHIPS

25 Nov 2025

The Push to Turn mRNA Into a Cancer Weapon

Pfizer and BioNTech deepen mRNA cancer vaccine development as competition grows and FDA signals supportive pathways

Automated production line filling COVID-19 vaccine vials in a sterile facility.

INSIGHTS

24 Nov 2025

Moderna’s Homegrown Bet Could Rewire Biotech’s Future

Moderna boosts US mRNA production, strengthening supply chains as firms like Pfizer explore on shore manufacturing

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.